Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ullum

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Vox Sanguinis|August 16, 2012
Characterization of blood donors with high haemoglobin concentrationK Magnussen, H C Hasselbalch, H Ullum, et al.
AIDS Research and Human Retroviruses|February 10, 1997
Increased plasma HIV type 1 RNA levels are associated with low levels of non-MHC class I-restricted cytotoxicityH Ullum, T Katzenstein, J Gerstoft, et al.
Transfusion Medicine (Oxford, England)|October 13, 2017
Iron deficiency among blood donors: experience from the Danish Blood Donor Study and from the Copenhagen ferritin monitoring schemeA S Rigas, O B Pedersen, K Magnussen, et al.
Clinical and Experimental Immunology|April 23, 2002
Proliferation and telomere length in acutely mobilized blood mononuclear cells in HIV infected patientsS R Søndergaard, M V Essen, P Schjerling, et al.
Scandinavian Journal of Infectious Diseases|December 7, 2006
Elevated levels of soluble urokinase receptor in serum from mycobacteria infected patients: still looking for a marker of treatment efficacyS R Ostrowski, P Ravn, G Hoyer-Hansen, et al.
Scandinavian Journal of Immunology|May 3, 2000
Immunological and virological changes in antiretroviral naïve human immunodeficiency virus infected patients randomized to G-CSF or placebo simultaneously with initiation of HAARTH Aladdin, H Ullum, T Katzenstein, et al.
Clinical and Experimental Immunology|July 28, 2005
2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapyS R Ostrowski, H Ullum, B K Pedersen, et al.
Scandinavian Journal of Immunology|December 6, 2008
Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markersS R Ostrowski, T L Katzenstein, B K Pedersen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 24, 1999
Immune function and phenotype before and after highly active antiretroviral therapyS R Søndergaard, H Aladdin, H Ullum, et al.
The Journal of Experimental Medicine|September 1, 1995
Defective natural immunity: an early manifestation of human immunodeficiency virus infectionH Ullum, P C Gøtzsche, J Victor, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Vox Sanguinis|August 16, 2012
Characterization of blood donors with high haemoglobin concentrationK Magnussen, H C Hasselbalch, H Ullum, et al.
AIDS Research and Human Retroviruses|February 10, 1997
Increased plasma HIV type 1 RNA levels are associated with low levels of non-MHC class I-restricted cytotoxicityH Ullum, T Katzenstein, J Gerstoft, et al.
Transfusion Medicine (Oxford, England)|October 13, 2017
Iron deficiency among blood donors: experience from the Danish Blood Donor Study and from the Copenhagen ferritin monitoring schemeA S Rigas, O B Pedersen, K Magnussen, et al.
Clinical and Experimental Immunology|April 23, 2002
Proliferation and telomere length in acutely mobilized blood mononuclear cells in HIV infected patientsS R Søndergaard, M V Essen, P Schjerling, et al.
Scandinavian Journal of Infectious Diseases|December 7, 2006
Elevated levels of soluble urokinase receptor in serum from mycobacteria infected patients: still looking for a marker of treatment efficacyS R Ostrowski, P Ravn, G Hoyer-Hansen, et al.
Scandinavian Journal of Immunology|May 3, 2000
Immunological and virological changes in antiretroviral naïve human immunodeficiency virus infected patients randomized to G-CSF or placebo simultaneously with initiation of HAARTH Aladdin, H Ullum, T Katzenstein, et al.
Clinical and Experimental Immunology|July 28, 2005
2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapyS R Ostrowski, H Ullum, B K Pedersen, et al.
Scandinavian Journal of Immunology|December 6, 2008
Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markersS R Ostrowski, T L Katzenstein, B K Pedersen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 24, 1999
Immune function and phenotype before and after highly active antiretroviral therapyS R Søndergaard, H Aladdin, H Ullum, et al.
The Journal of Experimental Medicine|September 1, 1995
Defective natural immunity: an early manifestation of human immunodeficiency virus infectionH Ullum, P C Gøtzsche, J Victor, et al.
Pageof 8